Next-generation Sequencing (NGS) Market Significant Market Size | Comprehensive Analysis, Industry Revenue, Forecast till 2020 – 2024

Next-generation Sequencing (NGS)

Next-generation Sequencing (NGS) Market” report presents a comprehensive overview, market shares, and growth opportunities of the Next-generation Sequencing (NGS) market by product type, application, key companies, and key regions. It comprehensively prepared with the main focus on the competitive landscape, geographical growth, segmentation, and market dynamics, including drivers, restraints, and opportunities. It offers a detailed analysis of the competition and leading companies of the global Next-generation Sequencing (NGS) market. It concentrates on the recent developments, sales, market value, production, gross margin, and other important factors of the business of top players operating in the global Next-generation Sequencing (NGS) market.

Market Overview:

  • The major factors, such as increasing applications of NGS, speed, cost, and accuracy, efficient replacement for traditional technologies, and drug discovery applications demanding NGS technology are expected to drive the growth of the overall market.
  • The rapid speed, cost, and accuracy of the NGS technology help in the growth of the market. This is attained with the help of modern DNA sequencing technology, which has contributed to the sequencing of complete DNA sequences of numerous types and species of life. It is also found that NGS is significantly cheaper, quicker, and needs significantly lesser DNA, which helps in the overall growth of the market.
  • The NGS has the potential to accelerate the early detection of disorders and the identification of pharmacogenetics markers to customize its treatments.
  • There are various technological advancements in the field of medicine that are growing at a rapid pace and has led to the development of personalized medicine. There are a huge number of applications of next-generation sequencing in personalized medicine. Thus, the development of personalized medicine has opened many avenues for the application of NGS, which could accelerate the market growth.
  • The current market is also facing challenges, owing to the difficulty in management of large data and complications, associated with Big Data management. In addition, some of the ethical issues associated with whole-genome sequencing, coupled with the lack of awareness among people, are pulling back the growth of the market.

    Request a Sample Copy of the Report –

    Scope of the Report:

    As per the scope of this report, NGS is a technology in which millions of DNA strands can be sequenced through massive parallelization; this technique is also known as high throughput sequencing. The low cost, high accuracy and speed, and precise results even from low sample input are the main advantages NGS offers over Sanger’s sequencing method. NGS is, therefore, being used to execute various applications, such as biomarker discovery, oncology studies, personalized medicine, and agricultural and animal research, among others. Thus, the NGS market has transformed the genomics and molecular diagnostics landscape.

    Top Manufacturers Are:

  • Agilent Technologies
  • DNASTAR Inc.
  • F. Hoffmann
  • La Roche Ltd
  • GATC Biotech AG
  • Illumina Inc.
  • Macrogen Inc.
  • Pacific Biosciences of California Inc.
  • PerkinElmer Inc.
  • Qiagen
  • Thermo Fisher Scientific Inc.

    Key Market Trends:

    Genetic Screening is the Segment Under Application that is Expected to Grow Fastest During the Forecast Period

    In genetic screening, the NGS is highly useful in identifying monogenic diseases with locus heterogeneity, such as blindness, deafness, movement disorders, mitochondrial disease, hereditary cancers, etc. Therefore, NGS has a large number of varied applications through genetic screening in multiple disorders, but their affordability and availability in high-income and low-income countries may differ a lot. The entire genomes are being mapped at affordable costs. Thus, steady growth is expected in the forecast period.

    The NGS is also emerging as a powerful promising pathogen-detection method for infectious-disease diagnostics. It helps in the identification and genomic characterization of bacteria, fungi, parasites, and viruses, without the need for prior knowledge of a specific pathogen, directly from clinical specimens. As the diseases caused by infections are increasing in the less-developed countries, the NGS-powered diagnosis of these infections has become the most promising method to detect these infectious diseases. The NGS also has applications in personalized medicine that has started becoming a reality and has been under application by various biotechnology companies.

    Asia-Pacific is the Fastest-growing Market and is Expected to Follow the Same Trend over the Forecast Period

    The market studied is expected to grow at the fastest pace in Asia-Pacific. The rising focus of the major market players is on delivering advanced, efficient NGS technology to the developing countries, in order to cater to the need for genomic medicines and whole genome sequencing for personalized medicine. In addition, the increasing adoption of NGS technology by the non-government and government bodies, along with increased investment of the private players, is expected to drive the Asian market.

    For More Information or Query or Customization Before Buying, Visit at –

    What Next-generation Sequencing (NGS) Market Research Offers:

    • Next-generation Sequencing (NGS) market gives evaluations for the regional level analysis with Production, Sales, Consumption, Imports, and Exports
    • Next-generation Sequencing (NGS) market forecasts for a minimum of 5 years of all the mentioned segments
    • Supply chain trends mapping the latest industrial advancements
    • Global Next-generation Sequencing (NGS) industry shares drivers, constraints, opportunities, threats, challenges, investment opportunities
    • Calculated for the new entrants in the Next-generation Sequencing (NGS) market
    • Manufacturing process, suppliers, price, production and consumption analysis, mode of transport and cost analysis, industry chain analysis
    • Next-generation Sequencing (NGS) market provides manufacturers with basic information, product category, sales revenue, price, and gross margin
    • Provide Company profiling with detailed strategies, financials, and recent developments

    And many more…

    Detailed TOC of Next-generation Sequencing (NGS) Market – Segmented by Geography – Growth, Trend, and Forecast:

    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study



    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Increasing Application in the Clinical Diagnosis
    4.2.2 Speed, Cost, and Accuracy to Spur the Market Growth
    4.2.3 Efficient Replacement for Traditional Technologies (Microarrays)
    4.2.4 Drug Discovery Applications Demanding NGS Technology
    4.3 Market Restraints
    4.3.1 Legal and Ethical Issues
    4.3.2 Interpretation of Complex Data and Lack of Skilled Professionals
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5.1 By Type of Sequencing
    5.1.1 Whole Genome Sequencing
    5.1.2 Targeted Resequencing
    5.1.3 Whole Exome Sequencing
    5.1.4 RNA Sequencing
    5.1.5 CHIP Sequencing
    5.1.6 De Novo Sequencing
    5.1.7 Methyl Sequencing
    5.2 By Product Type
    5.2.1 Instruments
    5.2.2 Reagents and Consumables
    5.2.3 Services
    5.3 By End User
    5.3.1 Hospitals and Healthcare Institutions
    5.3.2 Academics
    5.3.3 Pharmaceutical and Biotechnology Companies
    5.4 By Application
    5.4.1 Drug Discovery/Personalized Medicine
    5.4.2 Genetic Screening
    5.4.3 Diagnostics/Infectious Diseases
    5.4.4 Agriculture and Animal Research
    5.4.5 Other Applications
    5.5 Geography
    5.5.1 North America United States Canada Mexico
    5.5.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
    5.5.3 Asia-Pacific China Japan India Australia South korea Rest of Asia-Pacific
    5.5.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
    5.5.5 South America Brazil Argentina Rest of South America

    6.1 Company Profiles
    6.1.1 Agilent Technologies
    6.1.2 DNASTAR Inc.
    6.1.3 F. Hoffmann-La Roche Ltd
    6.1.4 GATC Biotech AG
    6.1.5 Illumina Inc.
    6.1.6 Macrogen Inc.
    6.1.7 Pacific Biosciences of California Inc.
    6.1.8 PerkinElmer Inc.
    6.1.9 Qiagen
    6.1.10 Thermo Fisher Scientific Inc.


    Purchase this Report (Price 4250 USD for single user license)


    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Medical Laser Market Share and Forecast by 2020 to 2026 | Top Key Players Analysis Covers Regions with Growth Value, Comprehensive Development Strategy, Global Size with Revenue and COVID-19 Impact

    Cough Medicine Market Size Forecast Analysis by Global Opportunities 2020: Development Status, Organization Share, Market Components, and Regional Outlook till 2026

    Airborne Radars Market 2020: Top Coverage of Key Companies with Size and Share, Expected Growth Analysis with Revenue, Future Trends and Technology Forecast by 2026

    Medical Implant Antibacterial Coating Market Share Value 2020 Industry Top Players, Trends, Global Growth Rate by Size Expansion Strategies 2026 Report Includes COVID-19 Analysis

    Blepharitis Drugs Market Share, Top Manufacturers 2020 Future Growth Rate, Industry Size, Business Strategy, Demand Status by 2026 Research Includes COVID-19 Analysis

    Curtain Wall Market in China Market Size Analysis 2020 Covers Business Development, Trends, Future Growth Rate, Demand Status and Regional Forecast till 2024 | COVID-19 Impact Analysis